Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease (2022)
Attributed to:
Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/evidoa2100009
Publication URI: http://dx.doi.org/10.1056/evidoa2100009
Type: Journal Article/Review
Parent Publication: NEJM Evidence
Issue: 1